Peter Huijgens


1992 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1992 2019


Interim Analysis on a Dutch HOVON Multicenter Randomized Open Label Phase II Trial on 3 Rituximab Dosing Schemes In Chronic ITP Patients:

Zwaginga, J. J., van der Holt, R., Biemond, B. J., Boekhorst, P. A. W., Levin, M., Vreughdenhil, A., Huijgens, P. C., Brand, A., van der Griend, R., Luten, M., Pruijt, H., de Weerdt, O., van Pampus, E., Zweegman, S., Hollestein, R. & Koene, H. R., 2010.

Research output: Contribution to conferencePaperAcademic